Hypothesis / aims of study
Urinary tract infection (UTI) is the most common bacterial infection independent of age. Currently, the gold standard for diagnosis of UTI is based on the presence of bacteria together with white blood cells in the urine to distinguish significant infection vs contamination. Unfortunately, white blood cell count in the urine is non-specific. An ideal biomarker would be elevated in the presence of all UTIs, regardless of causative organism, and not elevated in the absence of UTI, or the presence of systemic inflammatory disease. We hypothesised that interleukin-8 (IL-8), alone or in combination with another reactive protein, is a potential biomarker for UTI.
Study design, materials and methods
IL-8, IL-6, Lactoferrin, Uromodulin (Tamm–Horsfall protein-THP). and Procalcitonin levels were measured in urine samples sent to the regional clinical pathology laboratory for microbiology testing where the laboratory confirmed infection with Escherichia coli (n=80), Proteus spp (n=80) or Klebsiella spp (n=80) and culture negative/ no growth (n=75). All assays used were solid-phase sandwich ELISAs from commercial suppliers designed to measure the amount of target bound between a matched antibody pair. Statistical analysis was performed using the Wilcoxon rank sum test with continuity correction and with significance defined as p<0.05.
Interpretation of results
IL-8 and lactoferrin emerge as promising candidates for distinguishing UTIs and warrant further research to validate the findings and explore the clinical implications for UTI diagnosis and management. Since some no growth samples showed increased IL-8, the possibility of a systemic inflammatory condition raising interleukin levels needs to be excluded. Combined marker measurement may emerge as a strategy to increase sensitivity and specificity.